tiprankstipranks
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
India Market

NATCO Pharma Limited (NATCOPHARM) Price & Analysis

Compare
2 Followers

NATCOPHARM Stock Chart & Stats


---

NATCO Pharma Limited News

---

Financials

Quarterly

NATCOPHARM FAQ

What was NATCO Pharma Limited’s price range in the past 12 months?
NATCO Pharma Limited lowest stock price was ₹757.75 and its highest was ₹1638.35 in the past 12 months.
    What is NATCO Pharma Limited’s market cap?
    NATCO Pharma Limited’s market cap is ₹138.21B.
      When is NATCO Pharma Limited’s upcoming earnings report date?
      NATCO Pharma Limited’s upcoming earnings report date is Jun 02, 2025 which is in 91 days.
        How were NATCO Pharma Limited’s earnings last quarter?
        NATCO Pharma Limited released its earnings results on Feb 12, 2025. The company reported ₹7.4 earnings per share for the quarter, missing the consensus estimate of ₹19.4 by -₹12.
          Is NATCO Pharma Limited overvalued?
          According to Wall Street analysts NATCO Pharma Limited’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does NATCO Pharma Limited pay dividends?
            NATCO Pharma Limited pays a Notavailable dividend of ₹6 which represents an annual dividend yield of 0.78%. See more information on NATCO Pharma Limited dividends here
              What is NATCO Pharma Limited’s EPS estimate?
              NATCO Pharma Limited’s EPS estimate is 10.8.
                How many shares outstanding does NATCO Pharma Limited have?
                NATCO Pharma Limited has 179,109,860 shares outstanding.
                  What happened to NATCO Pharma Limited’s price movement after its last earnings report?
                  NATCO Pharma Limited reported an EPS of ₹7.4 in its last earnings report, missing expectations of ₹19.4. Following the earnings report the stock price went down -1.974%.
                    Which hedge fund is a major shareholder of NATCO Pharma Limited?
                    Currently, no hedge funds are holding shares in IN:NATCOPHARM
                    ---

                    NATCOPHARM Stock 12 Month Forecast

                    Average Price Target

                    ₹1,006.50
                    ▲(22.47% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"912":"₹912","1533":"₹1,533","1067.25":"₹1,067.3","1222.5":"₹1,222.5","1377.75":"₹1,377.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1100,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.10K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1006.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.01K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":913,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹913.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[912,1067.25,1222.5,1377.75,1533],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Sep<br/>2024","9":"Dec<br/>2024","12":"Feb<br/>2025","25":"Feb<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1173.72,1168.0492307692307,1162.3784615384616,1156.7076923076922,1151.0369230769231,1145.3661538461538,1139.6953846153847,1134.0246153846153,1128.3538461538462,1122.683076923077,1117.0123076923078,1111.3415384615384,1105.670769230769,{"y":1100,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1173.72,1160.856923076923,1147.993846153846,1135.1307692307691,1122.2676923076924,1109.4046153846155,1096.5415384615385,1083.6784615384615,1070.8153846153846,1057.9523076923076,1045.0892307692307,1032.226153846154,1019.363076923077,{"y":1006.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1173.72,1153.6646153846154,1133.6092307692309,1113.5538461538463,1093.4984615384615,1073.443076923077,1053.3876923076923,1033.3323076923077,1013.2769230769231,993.2215384615384,973.1661538461539,953.1107692307692,933.0553846153846,{"y":913,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":976.83,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":969.91,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1013.26,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":993.35,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1192.95,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1353.03,"date":1722470400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1532.65,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1396.44,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1399.08,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1412.36,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1396.29,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1173.72,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1173.72,"date":1738368000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Aurobindo Pharma Ltd
                    Cipla Ltd
                    Dr. Reddy's Laboratories Ltd.
                    Lupin Limited
                    Sun Pharmaceutical Industries Limited

                    Best Analysts Covering NATCOPHARM

                    1 Year
                    Rashmi SanchetiDolat Capital
                    Not Ranked
                    1 Year Success Rate
                    0/0 ratings generated profit
                    1 Year Average Return
                    0.00%
                    downgraded a sell rating 18 days ago
                    Copying Rashmi Sancheti's trades and holding each position for 1 Year would result in - of your transactions generating a profit, with an average return of 0.00% per trade.
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis